Drug research

ORKA-001

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisNCT07290569	ORKA	Phase 2	Active not recruiting	2027-06Estimated
An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisNCT07449702	ORKA	Phase 2	Recruiting	2030-05Estimated

ORKAActive not recruitingPrimary completion: 2027-06 · Estimated

Trial details

ORKARecruitingPrimary completion: 2030-05 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.